Therapy Areas: Oncology
PhotonPharma adds Dr. William Warren to board
23 January 2026 - PhotonPharma Inc, a developer of autologous cancer immunotherapies, announced on Thursday the appointment of William Warren, Ph.D. to its board of directors.PhotonPharma says that Dr...
Mabwell reports first patient dosed with 7MW4911 in US trial
23 January 2026 - Chinese biopharmaceutical company Mabwell (SHA:688062) announced on Thursday that the first patient has been dosed in a US clinical trial of its independently developed novel CDH17-t...
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
22 January 2026 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq: ATOS) announced on Wednesday that The Healthcare Technology Report has recognized the company's founder...
Avacta secures FDA clearance for second pre|CISION oncology programme
21 January 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration of the Investigational New Dru...
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
19 January 2026 - Precision oncology company Guardant Health Inc (Nasdaq: GH) announced on Monday that it has entered into a multi-year strategic collaboration with pharmaceutical firm Merck, known as...
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis
19 January 2026 - Biopharmaceutical company Akeso Inc (HKEX: 9926.HK) announced on Monday that the National Medical Products Administration Center for Drug Evaluation has accepted its supplemental New...